Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lot Consistency and Safety of Trumenba in Adolescents
NCT01830855Phase 3Completed
- Sponsor
- Pfizer
- Start
- Apr 2013
- Primary completion
- Apr 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 8
01
Overview
A Phase 3 trial of meningococcal group B vaccine in meningococcal disease, sponsored by Pfizer. Started Apr 2013; status: completed.
02
Drugs
meningococcal group B vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on NCT01830855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01830855.